Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO)

Historical Holders from Q4 2018 to Q4 2025

Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Symbol
ORGO on Nasdaq
Shares outstanding
126,273,814
Price per share
$5.18
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
68,404,092
Total reported value
$288,621,037
% of total 13F portfolios
0%
Share change
-1,036,014
Value change
-$3,951,240
Number of holders
118
Price from insider filings
$5.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ades Alan A. 18% -1.1% $68,298,698 22,319,836 0% Alan A. Ades 24 Jun 2025
Soleus Capital Master Fund, L.P. 9.9% $53,185,572 12,484,876 Soleus Capital Master Fund, L.P. 31 Dec 2024
NUSSDORF GLENN H 9.7% $51,688,923 12,248,560 Glenn H. Nussdorf 14 May 2025
First Light Asset Management, LLC 6.6% $40,632,986 8,309,404 Mathew P. Arens 30 Jun 2025
As of 30 Sep 2025, Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 118 institutional shareholders filing 13F forms. They hold 68,404,092 shares. of 126,273,814 outstanding shares (54%) .

Top 25 institutional shareholders own 51% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Soleus Capital Management, L.P. 9.6% 12,131,699 -1.7% 2.7% $51,195,770
MORGAN STANLEY 9.3% 11,796,725 -2.2% 0% $49,782,179
First Light Asset Management, LLC 5.9% 7,497,911 +11% 3% $31,641,184
VANGUARD GROUP INC 4% 5,036,020 -3.1% 0% $21,252,005
Assenagon Asset Management S.A. 3.8% 4,854,942 +70% 0.03% $20,487,855
BlackRock, Inc. 3.6% 4,584,937 -3.1% 0% $19,348,435
DEUTSCHE BANK AG\ 2.6% 3,284,330 +0.19% 0% $13,859,872
DIMENSIONAL FUND ADVISORS LP 2.3% 2,909,228 -6.3% 0% $12,277,338
ACADIAN ASSET MANAGEMENT LLC 1.4% 1,753,230 -28% 0.01% $7,394,000
GEODE CAPITAL MANAGEMENT, LLC 1.4% 1,724,632 +3% 0% $7,279,364
STATE STREET CORP 1.2% 1,520,914 +0.81% 0% $6,418,257
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.68% 862,645 -10% 0% $3,640,362
RENAISSANCE TECHNOLOGIES LLC 0.65% 821,500 +2.2% 0% $3,466,730
AQR CAPITAL MANAGEMENT LLC 0.56% 706,768 -1.4% 0% $2,982,561
BANK OF AMERICA CORP /DE/ 0.48% 611,685 +27% 0% $2,581,310
NORTHERN TRUST CORP 0.47% 594,107 -25% 0% $2,507,131
D. E. Shaw & Co., Inc. 0.41% 511,636 -17% 0% $2,159,104
UBS Group AG 0.39% 493,316 -1.2% 0% $2,081,794
Connor, Clark & Lunn Investment Management Ltd. 0.34% 428,834 -28% 0.01% $1,809,679
RAYMOND JAMES FINANCIAL INC 0.33% 416,487 -6.2% 0% $1,757,574
Wealth Dimensions Group, Ltd. 0.32% 407,965 0% 0.35% $1,721,612
STATE OF WISCONSIN INVESTMENT BOARD 0.32% 401,463 -24% 0% $1,694,174
Bank of New York Mellon Corp 0.29% 371,551 +2.1% 0% $1,567,945
SEGALL BRYANT & HAMILL, LLC 0.25% 318,725 -0.77% 0.02% $1,345,020
HighMark Wealth Management LLC 0.23% 293,029 0% 0.54% $1,236,584

Institutional Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 6,151,282 $31,834,200 +$5,489,265 $5.18 6
2025 Q3 68,404,092 $288,621,037 -$3,951,240 $4.22 118
2025 Q2 69,383,599 $253,970,094 +$15,169,464 $3.66 113
2025 Q1 64,527,988 $278,764,876 +$10,290,436 $4.32 135
2024 Q4 62,559,735 $200,193,714 -$3,087,106 $3.20 119
2024 Q3 63,509,832 $181,646,282 +$1,722,986 $2.86 110
2024 Q2 62,887,604 $176,087,321 +$16,663,592 $2.80 115
2024 Q1 56,577,706 $160,674,676 -$937,951 $2.84 122
2023 Q4 75,051 $306,959 +$184,983 $4.09 2
2023 Q3 52,084,925 $165,622,594 +$896,431 $3.18 102
2023 Q2 51,683,797 $171,584,877 -$2,456,583 $3.32 111
2023 Q1 53,442,433 $113,798,837 -$5,354,241 $2.13 130
2022 Q4 55,935,525 $150,462,195 +$2,054,700 $2.69 144
2022 Q3 48,930,422 $158,533,328 -$18,668,611 $3.24 138
2022 Q2 54,436,415 $265,621,470 -$5,602,250 $4.88 136
2022 Q1 54,705,699 $416,692,195 +$23,118,727 $7.62 143
2021 Q4 51,823,542 $478,649,659 -$13,227,490 $9.24 146
2021 Q3 53,311,129 $761,418,663 +$42,177,962 $14.24 142
2021 Q2 49,883,493 $829,086,497 +$409,740,826 $16.62 139
2021 Q1 24,624,573 $448,920,001 +$65,920,870 $18.22 98
2020 Q4 19,678,420 $148,185,218 +$112,822,085 $7.53 62
2020 Q3 4,975,105 $19,093,728 +$2,283,519 $3.84 46
2020 Q2 4,377,997 $16,747,945 +$2,231,312 $3.84 46
2020 Q1 3,842,850 $12,378,195 -$1,231,934 $3.23 48
2019 Q4 4,041,035 $19,437,798 +$10,034,365 $4.81 51
2019 Q3 1,886,070 $12,392,423 +$1,957,646 $6.57 34
2019 Q2 1,461,510 $11,108,205 +$4,998,229 $7.60 25
2019 Q1 812,507 $6,092,000 +$6,092,008 $7.50 17
2018 Q4 $10.15 1